Principal Scientist - CADD |
Emeryville, CA |
Etats-Unis |
Biomedical Research |
Global Discovery Chemistry |
Data Science |
13. Mai 2024 |
Principal Scientist - CADD |
San Diego, CA |
Etats-Unis |
Biomedical Research |
Global Discovery Chemistry |
Data Science |
13. Mai 2024 |
Principal Expert Plant Engineer |
Basel (City) |
Suisse |
Development |
Pharmaceuticals |
Recherche & Développement |
06. Mai 2024 |
Principal Clinical Data Scientist |
National |
Royaume-Uni de Grande-Bretagne et d'Irl. du Nord |
Development |
GCO GDD |
Recherche & Développement |
07. Mai 2024 |
Prin Clin Sci (Data Mgr) |
East Hanover, NJ |
Etats-Unis |
Development |
GCO GDD |
Recherche & Développement |
24. April 2024 |
Pricing Manager |
Sydney |
Australie |
International |
APMA IMI |
Accès au marché |
21. April 2024 |
Praktikant (m/w/d) der internen und externen Kommunikation |
Nürnberg |
Allemagne |
Corporate Affairs |
Communications & Engagement |
|
21. Februar 2024 |
Portfolio Manager, SA |
Adelaide |
Australie |
International |
APMA IMI |
Ventes |
07. Mai 2024 |
Portfolio Manager, NSW & ACT |
Sydney |
Australie |
International |
APMA IMI |
Ventes |
05. Mai 2024 |
Portfolio Account Specialist, SA |
Adelaide |
Australie |
International |
APMA IMI |
Ventes |
23. April 2024 |
PNH Specialist (Multiple locations may be considered) |
東京 |
Japon |
International |
IMI to be remapped |
Ventes |
18. April 2024 |
Planer zunanjih materialov /External Materials Planner |
Ljubljana |
République de Slovénie |
Operations |
Pharmaceuticals |
Opérations techniques |
30. April 2024 |
Pharmaziepraktikant (w/m/d) MS&T | ab 01.04.2024 oder früher |
Wehr |
Allemagne |
Operations |
SMALL MOLECULES |
|
09. Februar 2024 |
Pharmaziepraktikant (m/w/d) im Medical Competence Center ab November 2024 |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Allemagne |
International |
Pharmaceuticals |
|
02. Mai 2024 |
Pharmareferent*in Onkologie Brustkrebs Westen |
Schaftenau |
Autriche |
International |
Region Europe IMI |
Ventes |
16. April 2024 |
People Partner |
Seoul |
République de Corée |
People & Organization |
P&O TO BE REMAPPED |
Ressources humaines |
08. Januar 2024 |
People Engagement Expert |
Petaling Jaya |
Malaisie |
People & Organization |
P&O People Services and Technology |
Ressources humaines |
16. April 2024 |
People & Organization (HR) Internship (f/m/d) |
Schaftenau |
Autriche |
People & Organization |
P&O for Operations |
Ressources humaines |
09. Februar 2024 |
Pension and Benefits Lead - Germany (f/m/d) |
Munich (or) Nuremberg |
Allemagne |
People & Organization |
P&O CoE Total Rewards |
Ressources humaines |
18. März 2024 |
Patient Adherence Lead |
Sydney |
Australie |
International |
APMA IMI |
Recherche & Développement |
07. Mai 2024 |
PART-TIME Quality Manager & Qualified Person GMP |
Prague |
République tchèque |
Operations |
QUALITY |
Qualité |
24. April 2024 |
P&O Manager |
Shanghai |
Chine |
People & Organization |
P&O for IMI/CCO |
Ressources humaines |
20. März 2024 |
Order Management Specialist |
INSURGENTES |
Mexique |
Finance |
CTS |
Audit et Finance |
19. April 2024 |
Operations Associate |
Sydney |
Australie |
International |
APMA IMI |
Ventes |
12. Mai 2024 |
Operational Tax Manager (m/w/d) |
Munich (or) Nuremberg |
Allemagne |
Finance |
Global Finance |
Audit et Finance |
18. März 2024 |
Operational Scheduler - D365 Specialist (Temporary) |
Colleretto Giacosa |
Italie |
Oncology |
ADVANCED ACCELERATOR APPLICATIONS |
Opérations techniques |
08. Mai 2024 |
Operational Excellence Expert (m/f/d) |
Schaftenau |
Autriche |
Operations |
LARGE MOLECULES |
Opérations techniques |
26. April 2024 |
Omnichannel Engagement Manager (m/w/d) |
München oder Nürnberg |
Allemagne |
International |
Region Europe IMI |
Commercialisation |
18. April 2024 |
Omni-Channel Platform Manager |
Sydney |
Australie |
International |
APMA IMI |
Commercialisation |
15. Mai 2024 |
Netzwerkmanager (m/w/d), Prostate Cancer, Rheinland-Pfalz und Saarland |
Mainz |
Allemagne |
International |
Region Europe IMI |
Ventes |
19. April 2024 |
Negotiation Manager(m/d/w) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Allemagne |
Development |
Pharmaceuticals |
Recherche & Développement |
14. Mai 2024 |
MSL Tumeurs Solides - Nord Est |
Field Non-Sales (France) |
France |
International |
Pharmaceuticals |
Recherche & Développement |
29. April 2024 |
MSL Onco - Centre Ouest |
Pays de la Loire |
France |
International |
Region Europe IMI |
Recherche & Développement |
05. April 2024 |
MSL Manager - Hematology |
Shanghai (Shanghai) |
Chine |
International |
Pharmaceuticals |
Recherche & Développement |
14. Mai 2024 |
MSL Manager |
Panama |
Panama |
International |
Pharmaceuticals |
Recherche & Développement |
08. Mai 2024 |
MSL Cardio - Sud Ouest |
Aquitaine |
France |
International |
Region Europe IMI |
Recherche & Développement |
26. März 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
22. April 2024 |
MR |
Beijing (Beijing) |
Chine |
International |
Pharmaceuticals |
Ventes |
25. April 2024 |